Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Gasperini C, Ruggieri S
Drug Des Devel Ther. 2012; 6:175-86. Epub 2012 Jul 19. PMID: 22888218.Abstract